INABILITY TO CRAWL

INABILITY TO CRAWL was reported 58 times

These drug classes are most commonly taken by patients reporting INABILITY TO CRAWL:

# Drug Count
0 Benzodiazepine [EPC] 10
1 Anti-epileptic Agent [EPC] 7
2 Mood Stabilizer [EPC] 6
3 Nonsteroidal Anti-inflammatory Drug [EPC] 6
4 beta-Adrenergic Blocker [EPC] 5
5 Corticosteroid [EPC] 4
6 Atypical Antipsychotic [EPC] 3
7 Barbiturate [EPC] 3
8 Central Nervous System Stimulant [EPC] 3
9 Dietary Cholesterol Absorption Inhibitor [EPC] 3
10 Interferon beta [EPC] 3
11 Methylxanthine [EPC] 3
12 Serotonin-3 Receptor Antagonist [EPC] 3
13 HMG-CoA Reductase Inhibitor [EPC] 2
14 Osmotic Laxative [EPC] 2
15 Potassium Channel Blocker [EPC] 2
16 Proton Pump Inhibitor [EPC] 2
17 Sulfonylurea [EPC] 2
18 alpha-Adrenergic Blocker [EPC] 2
19 Acetylcholine Release Inhibitor [EPC] 1
20 Amide Local Anesthetic [EPC] 1
21 Angiotensin 2 Receptor Blocker [EPC] 1
22 Antiarrhythmic [EPC] 1
23 Antisense Oligonucleotide [EPC] 1
24 CD20-directed Cytolytic Antibody [EPC] 1
25 CD52-directed Cytolytic Antibody [EPC] 1
26 Calcium [EPC] 1
27 Catecholamine [EPC] 1
28 Cephalosporin Antibacterial [EPC] 1
29 Ester Local Anesthetic [EPC] 1
30 Factor Xa Inhibitor [EPC] 1
31 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
32 Histamine-1 Receptor Antagonist [EPC] 1
33 Histamine-2 Receptor Antagonist [EPC] 1
34 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1
35 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
36 Integrin Receptor Antagonist [EPC] 1
37 Neuromuscular Blocker [EPC] 1
38 Nitroimidazole Antimicrobial [EPC] 1
39 Non-Standardized Chemical Allergen [EPC] 1
40 Phosphodiesterase 5 Inhibitor [EPC] 1
41 Platelet Aggregation Inhibitor [EPC] 1
42 Provitamin D2 Compound [EPC] 1
43 Purine Antimetabolite [EPC] 1
44 Pyrimidine Synthesis Inhibitor [EPC] 1
45 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
46 Tissue-nonspecific Alkaline Phosphatase [EPC] 1
47 Vitamin C [EPC] 1
48 alpha-Adrenergic Agonist [EPC] 1
49 beta-Adrenergic Agonist [EPC] 1